Stakeholders' perspectives on access-to-medicines policy and research priorities in Latin America and the Caribbean: Face-to-face and web-based interviews

Health Research Policy and Systems

Volumn 12, Issue 1, 2014, Pages

  Azeredo, Thiago B ^a   Luiza, Vera L ^b   Oliveira, Maria A ^b   Emmerick, Isabel C M ^b,c   Bigdeli, Maryam ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Access to medicines; Health systems; Health systems research; Interviews; Latin America and the Caribbean; Priority setting; Web survey

Indexed keywords

NEW DRUG;

ACCESS TO MEDICINE; ARTICLE; CENTRAL AMERICA; COST CONTROL; E-MAIL; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; INTERNET; LOWEST INCOME GROUP; ONLINE SYSTEM; QUALITY CONTROL; REIMBURSEMENT; RESEARCH PRIORITY; SOUTH AND CENTRAL AMERICA;

ATTITUDE OF HEALTH PERSONNEL; COLOMBIA; DOMINICAN REPUBLIC; EL SALVADOR; EVIDENCE-BASED PRACTICE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; RESEARCH; SURINAME;

EID: 84903781146     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-12-31     Document Type: Article

References (27)

1. UN (United Nations) United Nations Millennium Declaration 2000, New York: United Nations Information Centre, UN (United Nations).
2. CIPIH - Commission on Intellectual Property Rights, Innovation and Public Health Public Health, Innovation and Intellectual Property Rights: Report of the Commission on Intellectual Property Rights, Innovation and Public Health 2006, Geneva: World Health Organization, CIPIH - Commission on Intellectual Property Rights, Innovation and Public Health.
3. Ministerial Summit on Health Research The Mexico Statement on Health Research: Knowledge for Better Health: Strengthening Health Systems 2004, Geneva: World Health Organization, Ministerial Summit on Health Research.
4. The Bamako Call to Action on Research for Health Strengthening Research for Health, Development, and Equity. Global Ministerial Forum on Research for Health 2008 2008, Geneva: World Health Organization, The Bamako Call to Action on Research for Health.
5. World Health Organization Global Strategy and Plan of Action: On Public Health, Innovation and Intellectual Property 2011, Geneva: World Health Organization, World Health Organization.
6. Terry RF, Allen L, Gardner CA, Guzman J, Moran M, Viergever RF, . CEWG Consultative Expert Working Group on Researh and Development Mapping global health research investments, time for new thinking - A Babel Fish for research data. Health Res Policy Syst 2012, 10:28. 10.1186/1478-4505-10-28, 3471018, 22938160, CEWG Consultative Expert Working Group on Researh and Development.
7. Working Group on Priority Setting Priority setting for health research: lessons from developing countries. Health Policy Plan 2000, 15:130-136. 10.1093/heapol/15.2.130, 10837035, Working Group on Priority Setting.
8. Nuyens Y. Setting priorities for health research: lessons from low- and middle-income countries. Bull World Health Organ 2007, 85:319-321. 10.2471/BLT.06.032375, 2636318, 17546314.
9. Adam T, Hsu J, Savignyde D, Lavis JN, Røttingen J-A, Bennett S. Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions?. Health Policy Plan 2012, 27:iv9-iv19.
10. Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst 2010, 8:36. 3018439, 21159163.
11. World Health Organization The World Medicines Situation 2004, Geneva: World Health Organization, World Health Organization.
12. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, Van Damme W. Access to medicines from a health system perspective. Health Policy Plan 2013, 28(7):692-704. 10.1093/heapol/czs108, 3794462, 23174879.
13. Bigdeli M, Javadi D, Hoebert J, Laing R, Ranson K. Health policy and system research in access to medicines: a prioritized agenda for low- and middle-income countries. Health Res Policy Syst 2013, 11:37. 10.1186/1478-4505-11-37, 3854087, 24124696.
14. Emmerick ICM, Oliveira MA, Luiza VL, Azeredo TB, Bigdeli M. Access to medicines in Latin America and the Caribbean (LAC): a scoping study. BMJ Open 2013, 3(5):e002224. 3646181, 23645920.
15. Urcullo G, Muñoz R, Bitrán R. Identification of Priority Research Questions in LAC within the Areas of Health Financing, Human Resources for Health and the Role of the Non-state Sector: Final Report 2008, Bitrán & Asociados: Santiago.
16. Ranson MK, Bennett SC. Priority setting and health policy and systems research. Health Res Policy Syst 2009, 7:27. 10.1186/1478-4505-7-27, 2796654, 19961591.
17. Tromp N, Baltussen R. Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers. BMC Health Serv Res 2012, 12:454. 10.1186/1472-6963-12-454, 3565954, 23234463.
18. Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001, 16:13-20.
19. Hogerzeil HV. The concept of essential medicines: lessons for rich countries. BMJ 2004, 329:1169-1172. 10.1136/bmj.329.7475.1169, 527702, 15539676.
20. Schünemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 1Guidelines for guidelines. Health Res Policy Syst 2006, 4:1-6. 10.1186/1478-4505-4-1, 1363721, 16390555.
21. Alliance for Health Policy and Systems Research Strengthening Health Systems: The Role and Promise of Policy and Systems Research 2004, Geneva: Alliance for Health Policy and Systems Research, Alliance for Health Policy and Systems Research.
22. Swanson RC, Cattaneo A, Bradley E, Chunharas S, Atun R, Abbas KM, Katsaliaki K, Mustafee N, Meier BM, Best A. Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan 2012, 27:iv54-iv61. 3529625, 23014154.
23. Ranson MK, Chopra M, Atkins S, Dal Poz MR, Bennett S. Priorities for research into human resources for health in low- and middle-income countries. Bull World Health Organ 2010, 88:435-443. 10.2471/BLT.09.066290, 2878144, 20539857.
24. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008, 2:e300. 10.1371/journal.pntd.0000300, 2553488, 18820747.
25. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. The Lancet 2002, 359:2188-2194.
26. Kohler JC, Baghdadi-Sabeti G. The World Medicines Situation 2011 - Good Governance for the Pharmaceutical Sector 2011, Geneva: World Health Organization.
27. Cook C, Heath F, Thompson RL. A meta-analysis of response rates in web-or internet-based surveys. Educ Psychol Meas 2000, 60:821-836.